EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Drivers of Emergency Department Use Among Oncology Patients in the Era of Novel Cancer Therapeutics: A Systematic Review

Lauren Fleshner iD, Andrew Lagree, Audrey Shiner, Marie Angeli Alera, Mateusz Bielecki, Robert Grant, Alex Kiss, Monika K Krzyzanowska, Ivy Cheng, William T Tran, Sonal Gandhi

The Oncologist · 11.12.2023 · 28 (12) · 1020-1033

DOI: 10.1093/oncolo/oyad161 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Oncologist, online erschienen am 11.06.2023. Verfasst von Lauren Fleshner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada. Hauptthemen laut MEDLINE: Emergency Service, Hospital, Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Associated Medical Services (AMS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients diagnosed with cancer are frequent users of the emergency department (ED). While many visits are unavoidable, a significant portion may be potentially preventable ED visits (PPEDs). Cancer treatments have greatly advanced, whereby patients may present with unique toxicities from targeted therapies and are often living longer with advanced disease. Prior work focused on patients undergoing cytotoxic chemotherapy, and often excluded those on supportive care alone. Other contributors to ED visits in oncology, such as patient-level variables, are less well-established. Finally, prior studies focused on ED diagnoses to describe trends and did not evaluate PPEDs. An updated systematic review was completed to focus on PPEDs, novel cancer therapies, and patient-level variables, including those on supportive care alone.

Methods

Three online databases were used. Included publications were in English, from 2012-2022, with sample sizes of ≥50, and reported predictors of ED presentation or ED diagnoses in oncology.

Results

45 studies were included. Six studies highlighted PPEDs with variable definitions. Common reasons for ED visits included pain (66%) or chemotherapy toxicities (69.1%). PPEDs were most frequent amongst breast cancer patients (13.4%) or patients receiving cytotoxic chemotherapy (20%). Three manuscripts included immunotherapy agents, and only one focused on end-of-life patients.

Conclusion

This updated systematic review highlights variability in oncology ED visits during the last decade. There is limited work on the concept of PPEDs, patient-level variables and patients on supportive care alone. Overall, pain and chemotherapy toxicities remain key drivers of ED visits in cancer patients. Further work is needed in this realm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Emergency Service, HospitalNeoplasmsHumansPatientsPainRetrospective Studies

Stichwörter der Autor:innen

emergency department utilizationoncologyquality improvementsystematic review

Autor:innen und Institutionen

  • Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Radiogenomics Laboratory, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Institute of Medical Sciences, University of Toronto, Toronto, Canada.
  • Temerty Centre for AI Research and Education, University of Toronto, Toronto, Canada.
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: Lauren Fleshner

Förderung

  • Associated Medical Services (AMS)

Zitieren

APA

Fleshner, L., Lagree, A., Shiner, A., Alera, M. A., Bielecki, M., Grant, R., Kiss, A., Krzyzanowska, M. K., Cheng, I., Tran, W. T., & Gandhi, S. (2023). Drivers of Emergency Department Use Among Oncology Patients in the Era of Novel Cancer Therapeutics: A Systematic Review. The Oncologist, 28(12), 1020-1033. https://doi.org/10.1093/oncolo/oyad161

Vancouver

Fleshner L, Lagree A, Shiner A, Alera MA, Bielecki M, Grant R, et al. Drivers of Emergency Department Use Among Oncology Patients in the Era of Novel Cancer Therapeutics: A Systematic Review. The Oncologist. 2023;28(12):1020-1033. doi:10.1093/oncolo/oyad161

BibTeX
@article{Fleshner2023,
  author = {Fleshner, Lauren and Lagree, Andrew and Shiner, Audrey and Alera, Marie Angeli and Bielecki, Mateusz and Grant, Robert and Kiss, Alex and Krzyzanowska, Monika K and Cheng, Ivy and Tran, William T and Gandhi, Sonal},
  title = {Drivers of Emergency Department Use Among Oncology Patients in the Era of Novel Cancer Therapeutics: A Systematic Review},
  journal = {The Oncologist},
  year = {2023},
  volume = {28},
  number = {12},
  pages = {1020--1033},
  doi = {10.1093/oncolo/oyad161}
}
Kostenlos starten →